Quoin Pharmaceuticals Announces Third Quarter 2023 Financial Results and Corporate Update Conference Call to be held on Thursday November 9th at 8:30 am ET
03 Novembro 2023 - 9:41AM
Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or
“Quoin”), a clinical stage specialty pharmaceutical company focused
on rare and orphan diseases, announced today that the Company plans
to release its third quarter 2023 financial results after the
market closes on Wednesday, November 8, 2023.
The Company will host a conference call and
webcast at 8:30am ET on Thursday, November 9, 2023. The
call will include a discussion of third quarter 2023 financial
results and a corporate update.
The live call can be accessed by dialing
1-800-603-0527 (domestic) or 1-412-317-0688 (international).
The live and archived webcast of the call will also be available
on the Quoin Pharmaceuticals website under the Investors section or
by following this link:
https://event.choruscall.com/mediaframe/webcast.html?webcastid=sPhSaNGJ
About Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd. is a clinical stage
specialty pharmaceutical company focused on developing and
commercializing therapeutic products that treat rare and orphan
diseases. We are committed to addressing unmet medical needs for
patients, their families, communities and care teams. Quoin’s
innovative pipeline comprises four products in development that
collectively have the potential to target a broad number of rare
and orphan indications, including Netherton Syndrome, Peeling Skin
Syndrome, Palmoplantar Keratoderma, Scleroderma, Epidermolysis
Bullosa and others. For more information,
visit: www.quoinpharma.com or LinkedIn for
updates.
For further information, contact:Investor
RelationsPCG AdvisoryStephanie
Princesprince@pcgadvisory.com (646) 863-6341
Quoin Pharmaceuticals (NASDAQ:QNRX)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Quoin Pharmaceuticals (NASDAQ:QNRX)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024